ISDA

Deposition Date 2017-08-31

Release Date 2018-08-01

Last Version Date 2024-11-20

Entry Detail

PDB ID:

5OWC

Keywords:

LIPID BINDING PROTEIN

Title:

Indole-2 carboxamides as selective secreted phospholipase A2 type X (sPLA2-X) inhibitors

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli BL21(DE3)

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.75 Å

R-Value Free:

0.22

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Group 10 secretory phospholipase A2
Gene (Uniprot):PLA2G10
Chain IDs:A, B
Chain Length:122
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:O15496 Pfam ID:PF00068 EC:3.1.1.4

Ligand Molecules

AYZ

DMS

PEG

Primary Citation

Discovery of a Series of Indole-2 Carboxamides as Selective Secreted Phospholipase A2Type X (sPLA2-X) Inhibitors.

Knerr, L, Giordanetto, F, Nordberg, P, Pettersen, D, Selmi, N, Beisel, H.G, de la Motte, H, Olsson, T, Perkins, T.D.J, Herslof, M, Mansson, A, Dahlstrom, M, Starke, I, Broddefalk, J, Saarinen, G, Klingegard, F, Hurt-Camejo, E, Rosengren, B, Brengdahl, J, Jansen, F, Rohman, M, Sandmark, J, Hallberg, K, Akerud, T, Roth, R.G, Ahlqvist, M.Show

Acs Med.Chem.Lett. 9 594 599 (2018)

PMID: 30034585 DOI: 10.1021/acsmedchemlett.7b00505

Abstact

In order to assess the potential of sPLA2-X as a therapeutic target for atherosclerosis, novel sPLA2 inhibitors with improved type X selectivity are required. To achieve the objective of identifying such compounds, we embarked on a lead generation effort that resulted in the identification of a novel series of indole-2-carboxamides as selective sPLA2-X inhibitors with excellent potential for further optimization.

Legend

Protein

Chemical

Disease

Primary Citation of related structures